Mutations common in pancreatic CA, history of other cancers

February 7, 2018

(HealthDay)—A substantial proportion of individuals with pancreatic cancer and a history of other hereditary breast and ovarian cancer (HBOC)- or Lynch syndrome (LS)-related cancers have mutations in a prostate cancer susceptibility gene, according to a study published online Jan. 23 in Cancer.

Beth Dudley, M.P.H., from the University of Pittsburgh, and colleagues used a pancreatic disease registry to identify 149 patients with pancreatic cancer and a history of cancer. For individuals who had not previously had a mutation identified through clinical testing or had undergone clinical multigene panel testing with no mutations detected, multigene panel testing was performed with banked DNA, if available.

The researchers found that 22 of 124 individuals with pancreatic cancer and another HBOC- or LS-related cancer (18 percent) had a mutation identified in a pancreatic cancer susceptibility gene. The mutation prevalence increased to 23 percent (21 of 93) when prostate cancer was excluded. Mutation carriers were significantly more likely to have had more than one previous cancer diagnosis, to have had clinical , and to have met National Comprehensive Cancer Network (NCCN) genetic testing criteria. However, nearly one-quarter of mutation carriers (23 percent) did not meet NCCN HBOC or LS testing guidelines based on either their personal cancer history or reported cancer history in first-degree relatives.

"At least 18 percent of individuals with pancreatic cancer and a personal history of other HBOC- or LS-related cancers carry mutations in a cancer susceptibility gene based on our data, suggesting that criteria for genetic testing in individuals with should include consideration of previous history," conclude the authors.

Several authors disclosed ties to biotechnology and genetic testing companies.

Explore further: Searching out pancreatic cancer risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Searching out pancreatic cancer risk

December 8, 2017
A prospective study by Wei Zheng, Ph.D., M.D., and colleagues delivers the first direct epidemiological evidence that increased production of a chemical compound called prostaglandin E2 (PGE2), as measured by metabolites ...

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

Genetic counseling helps determine risk for hereditary cancers

November 15, 2016
Knowing your family history is a key part in understanding your risk factors for certain diseases. While you're gathering with family this Thanksgiving, get to know more about your family's health history and how it could ...

Researchers propose new approach to identify genetic mutations in men with prostate cancer

June 29, 2017
Scientists have had limited success at identifying specific inherited genes associated with prostate cancer, despite the fact that it is one of the most common non-skin cancers among men. Researchers at University of Utah ...

Internists play a vital role in identifying patients for genetic counseling for cancer risk

October 30, 2017
Patients at high risk for familial cancer, history of cancer at a young age, or history of multiple cancer occurrences may be referred to genetic counseling for genetic testing from the primary care office, which makes internists ...

Gene identified in increasing pancreatic cancer risk

December 29, 2011
Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.